Quarterly ResultAug 6, 2026, 04:12 PM
Nutex Health Q2 Net Income $65.8M, EPS $9.38; H1 Net Income $112.6M
AI Summary
Nutex Health reported significantly improved financial results for Q2 and H1 2026. Net income attributable to Nutex Health for Q2 surged to $65.8 million, or $9.38 diluted EPS, compared to a loss in the prior year. For the first six months of 2026, net income reached $112.6 million, or $15.87 diluted EPS, a substantial increase from $3.5 million in H1 2025. The company also generated strong operating cash flow of $109.7 million for H1 2026, driven by lower operating costs, including a $52.3 million reduction in contract services expenses due to favorable arbitration-related changes.
Key Highlights
- Q2 2026 Net income attributable to Nutex Health increased to $65.8M from $(17.7)M YoY.
- Q2 2026 Diluted EPS was $9.38, up from $(2.95) YoY.
- H1 2026 Net income attributable to Nutex Health increased to $112.6M from $3.5M YoY.
- H1 2026 Diluted EPS was $15.87, up from $0.55 YoY.
- Q2 2026 Total revenue decreased 13.6% to $210.8M YoY.
- H1 2026 Total revenue decreased 6.3% to $427.2M YoY.
- H1 2026 Net cash provided by operating activities was $109.7M, up from $78.2M YoY.
- Contract services expense reduced by $52.3M due to HaloMD amendment and CMS fee decrease.
Price Impact
More from NUTX